GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
₹2,740.00
arrow_upward
+0.98%(+26.60) 1D
Nov 20, 3:30:03 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
Open
₹2,701.00
High
₹2,748.00
Low
₹2,680.00
Mkt. cap
464.17B
Avg. vol.
94.32K
Volume
84.48K
Dividend
2.08%
Quarterly dividend
₹14.25
Ex-dividend date
May 29, 2026
P/E ratio
40.48
52-wk high
₹3,120.70
52-wk low
₹2,088.10
EPS
₹67.68
Shares outstanding
169.41M
No. of employees
3K
News stories
From web sources and news partners
Benzinga
·
1 hour ago
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Weighs Iran Decision— INTU, ROST, KEYS in Focus
MarketForces Africa
·
3 hours ago
S&P 500, Nasdaq, Dow Jones Dip Amidst Anthropic IPO Debut
BeInCrypto
·
2 hours ago
S&P 500 Logs Its Longest Losing Streak Since 2024. Here’s What Happened Last Time
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd
CEO-
Employees3.1K
FoundedNov 13, 1924
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindia-pharma.gsk.com